NCT06605521View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

April 4, 2027

Study Completion Date

April 4, 2027

Conditions
Locally Advanced Breast Cancer
Interventions
PROCEDURE

Subclavian lymph node dissection+radiotherapy

The patient grouping is determined jointly by the researchers and participants, and patients in Group A are selected for supraclavicular lymph node dissection and radiotherapy.

PROCEDURE

Simple clavicular region radiotherapy

If the patient chooses Group B treatment plan, they will receive simple clavicle area radiotherapy.

Trial Locations (1)

450000

RECRUITING

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV